−£1.05m
vs Dec 2023Active05831644Private limited companyEgham
DIA PHARMA LIMITED
Significant control: Sarvesh Bhargava (significant control), Ranjana Bhargava (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Dia Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Dia Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DIA PHARMA LIMITED is an active private limited company (company number 05831644) incorporated on 30 May 2006, registered in Egham. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest abridged accounts cover the period ending 31 December 2024, showing net assets of −£1.05m and cash of £19k, with 0 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 124% on the prior period (−£468k).
Peer position · net assets
By net assets it sits in the bottom quarter of 319 comparable companies in Greater London (median £6,251, upper quartile £199k).
02
Ownership and control
- Mr Sarvesh Bhargava
- has significant influence or control
- Mrs Ranjana Bhargava
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 30 May 200620 yrs ago
- Next accounts due
- 30 September 202624 days overdue
- Confirmation statement due
- 13 June 2027in 232 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£19k
+9%vs Dec 2023Not disclosed
0
vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£1.05m | £19k | £179k | £1.29m | — | — | 0 |
| 31 December 2023 | −£468k | £17k | £529k | £1.21m | — | — | 0 |
Current ratio0.19Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-1,046,998 at 31 December 2024
- Net assets down 25% or more on the prior period-123.8% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.19
- Incorporated five or more years agoIncorporated 30 May 2006
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 232 days
- Next accounts due24 days overdue
- Accounts period endNet liabilities £1.05m · abridged accounts
- Accounts period endNet liabilities £468k · abridged accounts
- Incorporated
08
Similar companies in Greater London
- QUATROMED LIMITEDEssex · inc. May 2006
- NEILMED LIMITEDHarrow · inc. Jun 2006
- M BIOTECH LIMITEDEgham Surrey · inc. Aug 2006
- ANUVA INTERNATIONAL LIMITEDStanmore · inc. Nov 2006
- MANICHEM LIMITEDPinner · inc. Jan 2007
- ELITE PHARMA (SURREY) LIMITEDWest Molesey · inc. Feb 2007
All companies incorporated on 30 May 2006 · in May 2006.
09
Reminders for DIA PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.